← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Redbud Labs, Inc.
Durham, NC
$24,546,898
Total funding
21
Grants
Funding over time
peak $4.7M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,546,898 · 21
By mechanism
R44$17,331,651 · 8
R43$3,132,245 · 10
R42$1,986,695 · 1
N44$1,799,353 · 1
R41$296,954 · 1
Investigators at Redbud Labs, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Sample Preparation for In-Field Viral Discovery$1,799,353
N44 · FY2023 · AI
Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation$1,261,092
R44 · FY2025 · GM
Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation$1,238,908
R44 · FY2024 · GM
System for unitary automation of library preparation$1,235,487
R44 · FY2025 · GM
System for unitary automation of library preparation$1,223,863
R44 · FY2024 · GM
Device for rapid extraction of rare pathogens from raw samples$1,140,832
R44 · FY2018 · AI
HLS-Rugged point-of-care device for global hemostasis testing of whole blood$1,089,446
R44 · FY2016 · HL
System for faster microarray assays and end-to-end workflow automation$999,735
R44 · FY2019 · GM
Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood$999,676
R42 · FY2022 · GM
Rapid point-of-care molecular test for HCV VL$999,310
R44 · FY2024 · AI
A modular platform for infectious disease surveillance at point-of-need.$998,995
R44 · FY2022 · AI
Rapid point-of-care molecular test for HCV VL$996,914
R44 · FY2025 · AI
Device for rapid extraction of rare pathogens from raw samples$994,953
R44 · FY2019 · AI
System for faster microarray assays and end-to-end workflow automation$987,240
R44 · FY2020 · GM
Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood$987,019
R42 · FY2023 · GM
A modular platform for infectious disease surveillance at point-of-need.$983,642
R44 · FY2023 · AI
Point-of-care HIV viral load system using RPA and MXR$952,622
R44 · FY2022 · MH
Point-of-care HIV viral load system using RPA and MXR$950,372
R44 · FY2023 · MH
HLS-Rugged point-of-care device for global hemostasis testing of whole blood$391,868
R44 · FY2017 · HL
MEMS-enhanced solid-phase isothermal amplification for rapid, multiplexed molecular diagnostics$304,329
R43 · FY2022 · EB